Arrivillaga-Quintero M

Language: Spanish
References: 23
Page: 350-356
PDF size: 126.37 Kb.

ABSTRACT

Objective. To identify and analyze HIV/AIDS treatment adherence among Colombian women. Material and Methods. A qualitative, descriptive-interpretative study with content analysis was developed between 2008 and 2009. Sixty six women participated in five focus group discussions. To complement data, semi-structured interviews with seven key informants were conducted. Results. Main barriers are determined structurally by the current Colombian health system, based on insurance market. The right to access to treatment in a timely and continuous manner, the rights to confidentiality and non discrimination, and the right to quality care with gender focus are affected among participant women. Consequently, adherence is negatively affected. Conclusions. The current Colombian health system determines critical processes affecting HIV/AIDS treatment adherence in women. However, further research must be conducted to identify specific associations with non-universal health systems.

REFERENCES

1. Vega R, Hernández A. Evaluación de los efectos de la política de focalización de subsidios en salud sobre la población sin capacidad de pago de cuatro localidades de Bogotá, D.C., Colombia, 2001. Rev Salud Publica 2003;5(3):284-300.

2. Abadia CE, Oviedo DG. Bureaucratics itineraries in Colombia. A theoretical and methodological tool to assess managed-care health care system. Soc Sci Med 2009;68(6):1153-1160.

3. García Bernal R, Luque Núñez R, Mcdouall Lombana J, Moreno Díaz LA. Infección por vih y sida en Colombia. Estado del arte 2000-2005. Bogotá: ONUSIDA Colombia / Ministerio de la Protección Social de Colombia, 2006.

4. WHO, UNAIDS, UNICEF. Epidemiological Fact Sheet on HIV and AIDS. Core data on epidemiology and response. Colombia 2008 Update. Geneva: UNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance, 2008.

5. Ewig C, Hernández A. Gender equity and health sector reform in Colombia: Mixed state-market model yields mixed results. Soc Sci Med 2009;68(6):1145-1152.

6. Guanizo-Herreño C, Agudelo C. Equidad de género en el acceso a los servicios de salud en Colombia. Rev Salud Pública 2008;10(1):44-57.

7. Organización de las Naciones Unidas. Comité de Derechos Económicos, Sociales y Culturales. Observación General No. 14. El derecho al disfrute del más alto nivel posible de salud. Ginebra: ONU, 2000.

8. Deslauriers JP. Recherche qualitative: Guide pratique. Montréal: McGraw Hill, 1991.

9. ONUSIDA. Informe sobre la epidemia mundial del sida, 2008. Resumen de orientación. Ginebra: ONUSIDA, 2008.

10. Stevens PE, Keigher SM. Systemic barriers to health care access for U.S. women with HIV: The role of cost and insurance. Int J Health Serv 2009;39(2):225-243.

11. Arrivillaga M, Ross M, Useche B, Alzate ML, Correa D. Social position, gender role, and treatment adherence among Colombian women living with HIV/AIDS: social determinants of health approach. Panam J Public Health 2009;26(6):502-510.

12. World Health Organization/UNAIDS. Progress on global access to HIV antiretroviral therapy. Switzerland: WHO, 2006.

13. The Antiretroviral Therapy in Lower Income Countries (ART-LINC) Collaboration, ART Cohort Collaboration (ART-CC) groups. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet 2006;367:817-824.

14. Chi-Tai F, Hsu-Mei H, Shiing-Jer T, Mao-Yen C, Yu-Yin C, Jing-Shiang H, et al. Decreased HIV transmission after a policy of providing free access to highly active antiretroviral therapy in Taiwan. J Infect Dis 2004;190:879-885.

15. Teixeira PR, Vitória MA, Barcarolo J. Antiretroviral treatment in resource-poor settings: the Brazilian experience. AIDS 2004;18:S5-S7.

16. Ruiz-Torres Y, Cintrón-Bou F, Varas-Diaz N. AIDS-related stigma and health professionals in Puerto Rico. Interamerican J Psychology 2007;41(1):49-56.

17. Murray LK, Semrau K, McCurley E, Thea D, Scott N, Mwiya M, et al. Barriers to acceptance and adherence of antiretroviral therapy in urban Zambian women: a qualitative study. AIDS Care 2009;21(1):78-86.

18. Burke-Miller JK, Cook JA, Cohen MH, Hessol NA, Wilson TE, Richarson JL, et al. Longitudinal relationships between use of highly active antiretroviral therapy and satisfaction with care among women living with HIV/AIDS. Am J Public Health 2006;96(6):1044-1051.

19. Cotrim A, Dias M, Duarte S. Evaluation of the care of women living with HIV/AIDS in Sao Paulo Brazil. Aids Patient Care and STDs 2003;17(2):85-93.

20. Makwiza I, Nyirenda L, Bongololo G, Banda T, Chimzizi R, Theobald S. Who has access to counseling and testing and anti-retroviral therapy in Malawi - an equity analysis. Int J Equity Health 2009;8:13. doi:10.1186/1475-9276-8-13.

21. Hoang T, Goetz MB, Yano EM, Rossman B, Anaya, HD, Knapp H, et al. The impact of integrated HIV care on patient health outcomes. Med Care 2009;47(5):560-567. doi:10.1097/MLR.0b013e31819432a0.

22. Arrivillaga M, Alzate ML, Useche B. Políticas públicas, sistema de salud y mujeres con VIH/Sida en Colombia: Un análisis crítico. Rev Gerenc Polit Salud 2009;8(16):58-71.

23. Cardona A, Mejía L, Nieto E, Restrepo R. Temas críticos en la reforma de la Ley de seguridad social de Colombia en el capítulo de salud. Rev Fac Nac Salud Publica 2005;23(1):117-133.